20 ML voriconazole 10 MG/ML Injection — RxCUI 2727399
RxNorm drug concept · Semantic clinical drug
RxCUI 2727399
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2727399
Official name20 ML voriconazole 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvoriconazole 200 MG per 20 ML Injection; voriconazole 200 MG in 20 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Voriconazole: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats serious fungal infections. These include invasive aspergillosis, Candida infections in the blood or deep tissues, esophageal candidiasis, and certain Scedosporium and Fus...
- It is usually dosed every 12 hours as a tablet, oral suspension or IV infusion. High-fat meals can lower how much medicine you absorb, so ask me about timing with food. Follow your...
- Vision changes, fever, nausea, vomiting, rash, headache, chills, fast heartbeat and abnormal liver tests are common. Some people have hallucinations. Tell your doctor about anythin...
- Call for yellow skin or eyes, a fast or irregular heartbeat, fainting, a severe blistering or peeling rash, or vision problems that last. Also call for chest tightness or trouble b...
🕸️ Concept Web — How 20 ML voriconazole 10 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
20 ML voriconazole 10 MG/ML Injection
RxCUI 2727399 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Voriconazole
121243IN
-
Voriconazole
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Voriconazole Injection
1727280SCDF -
Voriconazole Injectable Product
1164590SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Voriconazole Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Voriconazole 10 MG/ML
2727398SCDC
-
Voriconazole 10 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Voriconazole 10 MG/ML
SCDC · 2727398 -
Voriconazole Injection
SCDF · 1727280 -
Voriconazole Injectable Product
SCDG · 1164590
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 2727399 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00121-1091-55 | 1 VIAL, SINGLE-USE in 1 CARTON (0121-1091-55) / 20 mL in 1... | Voriconazole | PAI Holdings, LLC dba PAI Pharma | 2026-05-14 |
| 14335-0730-10 | 1 VIAL, SINGLE-USE in 1 CARTON (14335-730-10) / 20 mL in 1... | VORICONAZOLE | Hainan Poly Pharm. Co., Ltd. | 2025-11-20 |
Observed labelers:
Hainan Poly Pharm. Co., Ltd. (1) ·
PAI Holdings, LLC dba PAI Pharma (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.